Acute Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity

NARecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 12, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
MCISCD
Interventions
DIETARY_SUPPLEMENT

Oral ketone monoester (KME)

The oral ketone monoester supplement should increase the global CBF and improve resting-state connectivity in the DMN in adults with SCD or MCI. The participants will take one dose of the supplement followed by measurement, to figure out if there are any noticeable changes.

Trial Locations (1)

4031

RECRUITING

University Hospital of Basel, Basel

All Listed Sponsors
collaborator

McMaster University

OTHER

lead

University Department of Geriatric Medicine FELIX PLATTER

OTHER